BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 10368032)

  • 1. The effects of cannabinoids on the brain.
    Ameri A
    Prog Neurobiol; 1999 Jul; 58(4):315-48. PubMed ID: 10368032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of cannabinoid agents in animals.
    Chaperon F; Thiébot MH
    Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
    Tanda G; Goldberg SR
    Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis: discrimination of "internal bliss"?
    Wiley JL
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.
    Sim-Selley LJ
    Crit Rev Neurobiol; 2003; 15(2):91-119. PubMed ID: 14977366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptors and their endogenous agonist, anandamide.
    Axelrod J; Felder CC
    Neurochem Res; 1998 May; 23(5):575-81. PubMed ID: 9566594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R; Hinz B
    J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
    Basavarajappa BS; Hungund BL
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.
    Panagis G; Vlachou S; Nomikos GG
    Curr Drug Abuse Rev; 2008 Nov; 1(3):350-74. PubMed ID: 19630731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
    Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
    Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
    Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
    Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.
    Ozaita A; Puighermanal E; Maldonado R
    J Neurochem; 2007 Aug; 102(4):1105-14. PubMed ID: 17484726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid physiology and pharmacology: 30 years of progress.
    Howlett AC; Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Porrino LJ
    Neuropharmacology; 2004; 47 Suppl 1():345-58. PubMed ID: 15464149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptors and their endogenous agonists.
    Felder CC; Glass M
    Annu Rev Pharmacol Toxicol; 1998; 38():179-200. PubMed ID: 9597153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular actions of cannabinoids and their generation during shock.
    Wagner JA; Varga K; Kunos G
    J Mol Med (Berl); 1998; 76(12):824-36. PubMed ID: 9846953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation.
    Do Y; McKallip RJ; Nagarkatti M; Nagarkatti PS
    J Immunol; 2004 Aug; 173(4):2373-82. PubMed ID: 15294950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.